MP 517 (Sotalol 240 mg)
Pill imprint MP 517 has been identified as Sotalol hydrochloride 240 mg.
Sotalol is used in the treatment of atrial fibrillation; atrial flutter; ventricular arrhythmia and belongs to the drug classes group III antiarrhythmics, non-cardioselective beta blockers. There is no proven risk in humans during pregnancy. Sotalol 240 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- MP 517
- Strength:
- 240 mg
- Color:
- Blue
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Group III antiarrhythmics
Non-cardioselective beta blockers - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mutual Pharmaceutical Company, Inc.
- National Drug Code (NDC):
- 53489-0291
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide colloidal
corn starch
magnesium stearate
microcrystalline cellulose
pregelatinized starch
sodium starch glycolate
stearic acid
FD&C Blue No. 2 Aluminium Lake
Note: Inactive ingredients may vary.
More about sotalol
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- 29 Reviews – Add your own review/rating
- Drug class: group III antiarrhythmics
Consumer resources
- Sotalol
- Sotalol oral solution
- Sotalol AF
- Sotalol (Advanced Reading)
- Sotalol Intravenous (Advanced Reading)
Other brands: Betapace, Sotalol Hydrochloride AF, Sotylize, Sorine, Betapace AF
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
